[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366856-105":59,"doc-detail-366856-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evidence-of-cancer-a-systematic-review-of-metabolomics-in-extracellular-vesicles-for-cancer-biomarker-detection","Evidence of cancer - a systematic review of metabolomics in extracellular vesicles for cancer biomarker detection","","Early cancer detection remains a major obstacle in clinical oncology, directly affecting survival and treatment success. This review evaluates how metabolomic profiling of extracellular vesicles (EVs) may support minimally invasive diagnosis and prognosis. EVs transport metabolite-rich cargo that reflects the disease state of their originating cells. A structured search identifies 12 studies reporting 1,602 metabolites, including 333 differentially regulated EV metabolites, while highlighting methodological variability and the need for standardized protocols.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evidence-of-cancer-a-systematic-review-of-metabolomics-in-extracellular-vesicles-for-cancer-biomarker-detection/366856/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evidence-of-cancer-a-systematic-review-of-metabolomics-in-extracellular-vesicles-for-cancer-biomarker-detection/366856.png","ImageObject",300,407,{"name":92,"@type":93},"OmBimo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this systematic review?","Question",{"text":112,"@type":113},"To systematically examine existing literature on metabolomic analysis of extracellular vesicles in cancer and clarify potential metabolite biomarker candidates.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many studies and metabolites were included?",{"text":117,"@type":113},"Twelve eligible studies were included, collectively reporting 1,602 identified metabolites across cancer types and experimental conditions.",{"name":119,"@type":110,"acceptedAnswer":120},"What limitation does the review emphasize?",{"text":121,"@type":113},"Methodological variability—differences in EV isolation and metabolomic analytical techniques—likely contributes to inconsistent findings across studies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366856,1790197466,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Metabolomics (2026) 22:13  \n[https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1306-025-02386-1  \nREVIEW ARTICLE  \nEvidence of cancer: a systematic review of metabolomics in extracellular vesicles for cancer biomarker detection  \nMegan Mayhew1 · Oliver Megram1 · Simmie Roshan1 · Marshall J. Smith2,5 · Samuel J. White3,5 · Philippe B. Wilson4,5 · John A. Hunt5 · Luigi De Girolamo1 · Victoria James6 · Elena Hunter5  \nReceived: 11 June 2025 / Accepted: 17 November 2025 / Published online: 16 December 2025 © The Author(s) 2025  \nAbstract  \nBackground The early detection of cancer remains a critical challenge in clinical oncology, with significant implications for patient survival rates and treatment outcomes. Research focus has shifted to developing minimally invasive diagnostic approaches for cancer detection and prognosis, such as metabolomic analysis of biological fluids and tumour-derived components, including extracellular vesicles (EVs) . EVs carry molecular cargo, including metabolites, that reflect the pathophysiological state of their cell of origin. Analysis and characterisation of these metabolites may offer novel insights into cancer biology and facilitate the identification of potential biomarkers.  \nAim of review This review systematically examines existing literature on the metabolomic analysis of EVs in the context of cancer to obtain a deeper understanding of potential metabolite biomarkers associated with cancer.  \nKey scientific concepts of review A comprehensive search of PubMed, Scopus, and Web of Science was conducted using a defined strategy to identify studies analysing EV-derived metabolites in cancer. Twelve eligible studies were included, collectively reporting 1,602 identified metabolites across various cancer types, sample sources, EV isolation methods, and metabolomic techniques. Of these, 333 metabolites were reported to be differentially regulated in EVs derived from patients with cancer, or conditioned medium from cancerous cell lines and their respective healthy controls. The review highlights the potential of EV metabolomics to detect cancer biomarkers but also underscores methodological variability as a major limitation. Differences in isolation and analytical techniques likely contribute to inconsistent findings, emphasising the need for standardised protocols in future research.  \nKeywords Metabolomics · Extracellular vesicles · Biomarkers · Cancer · Metabolites  \n􀀍 Elena Hunter [elena.hunter@ntu.ac.uk](elena.hunter@ntu.ac.uk)  \n1 School of Science and Technology, Nottingham Trent University, Nottingham, UK  \n2 Present address: Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Bethesda, MD 20892, USA  \n3 Present address: Centre for Applied Innovation, York St John University, York, UK  \n4 Present address: York St John University, York, UK  \n5 Medical Technologies Innovation Facility, Nottingham Trent University, Nottingham, UK  \n6 Biodiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK  \n1 Introduction  \nDetecting cancer early and accurately continues to pose a significant challenge in modern healthcare, with only 54% of cases in England being diagnosed at stage 1 or 2 in 2021 (NHS Digital, 2023). When detected, diagnosed, and treated early, the likelihood of survival increases significantly for almost all types of cancer due to improved treatment options (Crosby et al., 2022).Screening techniques often focus on specific cancer types, such as mammograms, pap smears, and prostate-specific antigen tests. These techniques are typically only offered to predetermined target populations, which may result in missed diagnoses (Weller & Campbell, 2009) . Furthermore, these screening techniques have individual limitations, including sensitivity, specificity, and patient participation in screening initiatives (Barry, 2001; Ferreira et al., 2021; Grimm et al., 2022; Migli","cbCaitbfvKTmaa9w","https://ap.wps.com/l/cbCaitbfvKTmaa9w","pdf",1523695,18,"English","# Abstract\n## Background\n## Aim of review\n## Key scientific concepts of review\n## Keywords\n# Introduction\n## Early detection challenges\n## Screening approaches and limitations\n## Tumour biopsy and its constraints\n## Liquid biopsy and metabolomics rationale","[{\"question\":\"What is the main purpose of this systematic review?\",\"answer\":\"To systematically examine existing literature on metabolomic analysis of extracellular vesicles in cancer and clarify potential metabolite biomarker candidates.\"},{\"question\":\"How many studies and metabolites were included?\",\"answer\":\"Twelve eligible studies were included, collectively reporting 1,602 identified metabolites across cancer types and experimental conditions.\"},{\"question\":\"What limitation does the review emphasize?\",\"answer\":\"Methodological variability—differences in EV isolation and metabolomic analytical techniques—likely contributes to inconsistent findings across studies.\"}]","Evidence of cancer - a systematic review of metabolomics in extracellular vesicles for cancer biomarker detection | PDF",1790167968,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/acf2149a8629515e9340f2e8854cffc6.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85de9a61b41e92ac16470f6df391a654.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a2ba5656f3aa6c3694dbc40ddfcb8a1.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21376b5dd5f36c06e1ff2d046ada2de6.webp",980,1301]